{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:16:14Z","timestamp":1787019374165,"version":"build-2736575974"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The prognostic significance of urinary N-acetyl-\u03b2-D-glucosamidase in acute heart failure has not been fully elucidated. Accordingly, this study investigated whether urinary N-acetyl-\u03b2-D-glucosamidase could be associated with subsequent adverse events in acute heart failure patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We studied 708 consecutive acute heart failure patients who had accessible N-acetyl-\u03b2-D-glucosamidase data on admission from the National Cerebral and Cardiovascular Center Acute Decompensated Heart Failure registry. We assessed the relationship between the admission N-acetyl-\u03b2-D-glucosamidase level and the combined endpoint of all-cause death and worsening heart failure. Worsening heart failure was defined as worsening symptoms and signs of heart failure requiring intensification of intravenous therapy such as diuretics, vasodilators and inotropes or initiation of mechanical support after stabilisation with initial treatment during hospitalisation, or readmission due to heart failure after discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>During a median follow-up period of 763 (interquartile range 431\u20131028) days, higher urinary N-acetyl-\u03b2-D-glucosamidase was significantly related to increased events of all-cause death and worsening heart failure. In addition, patients with higher urinary N-acetyl-\u03b2-D-glucosamidase and lower estimated glomerular filtration rate on admission had the worst clinical outcomes. In multivariable Cox regression, urinary N-acetyl-\u03b2-D-glucosamidase on admission was independently associated with adverse events (hazard ratio 1.19, 95% confidence interval 1.04\u20131.35) even after adjustment by covariates including the baseline estimated glomerular filtration rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Higher urinary N-acetyl-\u03b2-D-glucosamidase level on admission was independently associated with worse clinical outcomes. Our findings indicate the potential value of assessing urinary N-acetyl-\u03b2-D-glucosamidase on admission for further risk stratification in patients with acute heart failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/2048872620901986","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:05:39Z","timestamp":1580227539000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Elevated admission urinary\n                    <i>N<\/i>\n                    -acetyl-\u03b2-D-glucosamidase level is associated with worse long-term clinical outcomes in patients with acute heart failure"],"prefix":"10.1093","volume":"9","author":[{"given":"Sayaka","family":"Funabashi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Omote","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"},{"name":"Department of Cardiovascular Medicine, Hokkaido University, Japan"},{"name":"National Heart and Lung Institute, Imperial College London, UK"},{"name":"Robertson Centre for Biostatistics, University of Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotsugu","family":"Iwakami","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Hamatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michikazu","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Statistics and Data Analysis, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Statistics and Data Analysis, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Asaumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Aiba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan"},{"name":"Department of Cardiovascular Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"key":"2021020117063749700_bibr1-2048872620901986","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrcardio.2015.134","article-title":"Pathophysiology and clinical evaluation of acute heart failure","volume":"13","author":"Mentz","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2021020117063749700_bibr2-2048872620901986","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","article-title":"Renal function, neurohormonal activation, and survival in patients with chronic heart failure","volume":"102","author":"Hillege","year":"2000","journal-title":"Circulation"},{"key":"2021020117063749700_bibr3-2048872620901986","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"2021020117063749700_bibr4-2048872620901986","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCOUTCOMES.109.854877","article-title":"A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program","volume":"3","author":"Peterson","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2021020117063749700_bibr5-2048872620901986","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2021020117063749700_bibr6-2048872620901986","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199000394-00004","article-title":"Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function","volume":"39","author":"Ljungman","year":"1990","journal-title":"Drugs"},{"key":"2021020117063749700_bibr7-2048872620901986","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2021020117063749700_bibr8-2048872620901986","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/eurjhf\/hfq195","article-title":"Central venous pressure and impaired renal function in patients with acute heart failure","volume":"13","author":"Uthoff","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2021020117063749700_bibr9-2048872620901986","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehr190","article-title":"Clinical outcome of renal tubular damage in chronic heart failure","volume":"32","author":"Damman","year":"2011","journal-title":"Eur Heart J"},{"key":"2021020117063749700_bibr10-2048872620901986","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/ndt\/17.11.1890","article-title":"Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis","volume":"17","author":"Bazzi","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2021020117063749700_bibr11-2048872620901986","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1681\/ASN.2006030221","article-title":"Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure","volume":"18","author":"Liangos","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2021020117063749700_bibr12-2048872620901986","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1172\/JCI23056","article-title":"Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury","volume":"115","author":"Mori","year":"2005","journal-title":"J Clin Invest"},{"key":"2021020117063749700_bibr13-2048872620901986","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00392-015-0899-z","article-title":"Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure","volume":"105","author":"Otaki","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"2021020117063749700_bibr14-2048872620901986","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ejhf.537","article-title":"Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure","volume":"18","author":"Nagai","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2021020117063749700_bibr15-2048872620901986","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure; from the Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N Engl J Med"},{"key":"2021020117063749700_bibr16-2048872620901986","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"2021020117063749700_bibr17-2048872620901986","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure; from the PROTECT study","volume":"363","author":"Massie","year":"2010","journal-title":"N Engl J Med"},{"key":"2021020117063749700_bibr18-2048872620901986","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/eurjhf\/hfs087","article-title":"Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events","volume":"14","author":"Collins","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2021020117063749700_bibr19-2048872620901986","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jchf.2013.05.007","article-title":"Tubular damage and worsening renal function in chronic heart failure","volume":"1","author":"Damman","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2021020117063749700_bibr20-2048872620901986","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/hrt.2010.194878","article-title":"Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate","volume":"96","author":"Damman","year":"2010","journal-title":"Heart"},{"key":"2021020117063749700_bibr21-2048872620901986","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ejheart.2008.07.001","article-title":"Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure","volume":"10","author":"Damman","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2021020117063749700_bibr22-2048872620901986","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ejhf.426","article-title":"Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome","volume":"18","author":"Emmens","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2021020117063749700_bibr23-2048872620901986","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/eurjhf\/hfr102","article-title":"Kidney injury molecule-1 and N-acetyl-\u00df-d-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome","volume":"13","author":"Jungbauer","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2021020117063749700_bibr24-2048872620901986","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/erc.12.26","article-title":"Role of biomarkers in the diagnosis and prognosis of acute kidney injury in patients with cardiorenal syndrome","volume":"10","author":"Taub","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2021020117063749700_bibr25-2048872620901986","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14712\/18059694.2018.35","article-title":"The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment","volume":"48","author":"Skalova","year":"2005","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"2021020117063749700_bibr26-2048872620901986","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/ndt\/gfn007","article-title":"Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2021020117063749700_bibr27-2048872620901986","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.117.030112","article-title":"Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury","volume":"137","author":"Ahmad","year":"2018","journal-title":"Circulation"},{"key":"2021020117063749700_bibr28-2048872620901986","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jjcc.2014.02.016","article-title":"Association of plasma thioredoxin-1 with renal tubular damage and cardiac prognosis in patients with chronic heart failure","volume":"64","author":"Otaki","year":"2014","journal-title":"J Cardiol"},{"key":"2021020117063749700_bibr29-2048872620901986","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1253\/circj.CJ-13-0187","article-title":"Clinical features and outcome in hospitalized heart failure in Japan; from the ATTEND Registry","volume":"77","author":"Sato","year":"2013","journal-title":"Circ J"}],"container-title":["European Heart Journal. Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2048872620901986","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2048872620901986","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ehjacc\/article-pdf\/9\/5\/429\/36165889\/ehjacc0429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjacc\/article-pdf\/9\/5\/429\/36165889\/ehjacc0429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T20:19:53Z","timestamp":1618863593000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/9\/5\/429-436\/6125593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,8,1]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1177\/2048872620901986","relation":{},"ISSN":["2048-8734","2048-8726"],"issn-type":[{"value":"2048-8734","type":"electronic"},{"value":"2048-8726","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,8,1]]},"published":{"date-parts":[[2020,8,1]]}}}